These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28886004)

  • 1. Uncovering cancer: How enlisting T cells can boost the power of immunotherapy.
    Keener AB
    Nat Med; 2017 Sep; 23(9):1006-1008. PubMed ID: 28886004
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune regulation by CD8
    Zhang S; Wu M; Wang F
    Cell Mol Immunol; 2018 Sep; 15(9):805-807. PubMed ID: 29503446
    [No Abstract]   [Full Text] [Related]  

  • 3. Gut Microbes May Shape Response to Cancer Immunotherapy.
    Hampton T
    JAMA; 2018 Feb; 319(5):430-431. PubMed ID: 29411013
    [No Abstract]   [Full Text] [Related]  

  • 4. The status of tumor immunology and cancer immunotherapy. Introduction.
    Sogn JA
    Immunol Invest; 2000 May; 29(2):81-4. PubMed ID: 10854171
    [No Abstract]   [Full Text] [Related]  

  • 5. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
    Nelson B
    Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
    [No Abstract]   [Full Text] [Related]  

  • 6. Options for T-cell based therapies.
    Heslop HE; Gottschalk SM; Bollard CM; Straathof KC; Huls MH; Brenner MK; Rooney CM
    Vox Sang; 2004 Jul; 87 Suppl 2():230-4. PubMed ID: 15209923
    [No Abstract]   [Full Text] [Related]  

  • 7. Breakthrough of the year 2013. Cancer immunotherapy.
    Couzin-Frankel J
    Science; 2013 Dec; 342(6165):1432-3. PubMed ID: 24357284
    [No Abstract]   [Full Text] [Related]  

  • 8. Harnessing the power of Vδ2 cells in cancer immunotherapy.
    Fowler DW; Bodman-Smith MD
    Clin Exp Immunol; 2015 Apr; 180(1):1-10. PubMed ID: 25469879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodically Pulsed Immunotherapy in a Mathematical Model of Tumor, CD4
    Wei HC; Yu JL; Hsu CY
    Comput Math Methods Med; 2017; 2017():2906282. PubMed ID: 29250133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-15: targeting CD8+ T cells for immunotherapy.
    Diab A; Cohen AD; Alpdogan O; Perales MA
    Cytotherapy; 2005; 7(1):23-35. PubMed ID: 16040381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes.
    Klevorn LE; Berrien-Elliott MM; Yuan J; Kuehm LM; Felock GD; Crowe SA; Teague RM
    Cancer Immunol Res; 2016 Dec; 4(12):1016-1026. PubMed ID: 27803062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of T-cell directed cellular therapies in Australia.
    Moss DJ; Khanna R; Gandhi M
    Cytotherapy; 2007; 9(3):222-4. PubMed ID: 17464752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble γc receptor attenuates anti-tumor responses of CD8
    Kim G; Hwang H; Jo Y; Lee B; Lee YH; Kim CH; Hong C
    Int J Cancer; 2018 Sep; 143(5):1212-1223. PubMed ID: 29577276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
    Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
    Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
    Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Intrinsic Barriers of T Cell-Based Immunotherapy.
    Ghoneim HE; Zamora AE; Thomas PG; Youngblood BA
    Trends Mol Med; 2016 Dec; 22(12):1000-1011. PubMed ID: 27825667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
    Wang RF
    Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy.
    Bender E
    Nature; 2017 Dec; 552(7685):S61. PubMed ID: 29293244
    [No Abstract]   [Full Text] [Related]  

  • 19. Promising immunotherapy technique.
    Fillon M
    J Natl Cancer Inst; 2012 Oct; 104(20):1528-9. PubMed ID: 23044382
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.
    Majchrzak K; Nelson MH; Bailey SR; Bowers JS; Yu XZ; Rubinstein MP; Himes RA; Paulos CM
    Cancer Immunol Immunother; 2016 Mar; 65(3):247-59. PubMed ID: 26825102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.